2C-MMDA-3a
pharmaceutical compound
2C-MMDA-3a, also known as 2C-3a, MMDPEA-3a, or 2-methoxy-3,4-methylenedioxyphenethylamine (2-methoxy-MDPEA), is a psychoactive drug of the phenethylamine and MDxx families related to 3,4-methylenedioxyphenethylamine (MDPEA). It is the phenethylamine (2C) analogue of MMDA-3a and the 2-methoxy derivative of MDPEA. According to Alexander Shulgin in his 1991 book PiHKAL (Phenethylamines I Have Known and Loved), 2C-MMDA-3a has a dose range of 40 to 120 mg orally with marginal effects. At 40 mg, there was perhaps the hint of a psychic energizer (antidepressant); at 65 mg, there was pleasant mood elevation; and at 80 and 120 mg, there was brief parasthesia. Shulgin has noted the modest change in effects with the drug over a three-fold dose range and has wondered whether it might be useful as an antidepressant or might be a serotonin reuptake inhibitor. The chemical synthesis of 2C-MMDA-3a has been described. It was first described in the scientific literature by Shulgin and colleagues by 1969.
The public source identifies “2C-MMDA-3a” as pharmaceutical compound. This brief keeps that definition visible, then builds a research path around 2C-MMDA-3a, pharmaceutical and compound.
Why this record matters
A short description can identify a subject without explaining its stakes. For “2C-MMDA-3a”, the useful work is to connect “pharmaceutical compound” to the records capable of establishing context and consequence.
Named sources, stable identifiers and responsible institutions provide the strongest route from overview to verifiable evidence. The source revision retrieved here is dated Oct 30, 2025. The linked authority identifier is Q136773926. None of the 0 selected statements returned an explicit reference. The first chronological checks are 1991 and 1969.
The absence of detail may reflect summary conventions rather than a lack of surviving documentation. The source lead contains qualifying language; that uncertainty should survive quotation, summary and reuse. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Use the entry as an orientation point, then follow its citations and revision history. Names, dates and institutional relationships should be checked against the original record.
- Subject orientation
- Search vocabulary
- Locating named sources
The closest primary source, responsible institution and strongest cited specialist reference.
Three-step research path
- Establish the record: confirm the title “2C-MMDA-3a”, its source revision and the description used here.
- Expand the search: follow 2C-MMDA-3a primary sources, 2C-MMDA-3a archive and 2C-MMDA-3a research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “2C-MMDA-3a”?
- Which institution is responsible for the underlying evidence?
- What terminology or title could unlock a more precise catalogue search?
Search terms from this dossier
This entry incorporates text from “2C-MMDA-3a” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.